Eli Lilly to seek approval for new weight loss drug

Pharmaceutical manufacturer Eli Lilly has announced that it will seek approval from the Food and Drug Administration (FDA) to market the weight loss drug orforglipron.

According to the New York Times, the GLP-1 drug is administered in a daily pill, unlike popular injectable GLP-1s like Ozempic and Wegovy. Participants in Lilly’s clinical trials lost an average of 27.3 pounds each.